Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with ...

Tirzepatide was superior to semaglutide in achieving standard and intensive cardiometabolic targets among patients with type ...

Apartment Therapy spoke to top DIY TikTokers to get their expert opinions on which DIY trends they're ready to ditch in 2025, and what they see coming next. If you're looking for a fresh - not ...

Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...

The DIY home improvement market is experiencing significant growth, with a projected compound annual growth rate (CAGR) of over 4% through 2027. This surge is fueled by the increased interest in ...

Researchers conducted a post hoc analysis of the SURMOUNT-1 trial to assess the effect of tirzepatide on kidney function in prediabetes with obesity or overweight.

Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both ...

Dispensations of tirzepatide and semaglutide increased significantly in recent years while the use of other glucose-lowering and weight-lowering therapies declined, an analysis showed.The findings ...

New data from the SURPASS trial program showed that tirzepatide lowered HbA1c in adults with type 2 diabetes receiving once-daily insulin glargine. It was the top story in endocrinology last week.

The Food and Drug Administration approved Eli Lilly's tirzepatide drug for weight loss, paving the way for even wider use of the blockbuster medication. The active ingredient in the drug ...